This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Raymond James analyst John Freeman downgraded ConocoPhillips (NYSE:COP) from Strong Buy to Outperform and lowered the price target from $157 to $124. ConocoPhillips shares closed at $98.36 on Friday. See how other analysts view this stock.
• Barclays analyst Luke Sergott downgraded Illumina, Inc. (NASDAQ:ILMN) from Equal-Weight to Underweight and lowered the price target from $130 to $100. Illumina shares closed at $111.06 on Friday. See how other analysts view this stock.
• Citigroup analyst David Lebowitz downgraded Pliant Therapeutics, Inc. (NASDAQ:PLRX) from Buy to Neutral and lowered the price target from $44 to $4. Pliant Therapeutics shares closed at $7.79 on Friday. See how other analysts view this stock.
• UBS analyst Jon Windham downgraded the rating for Altus Power, Inc. (NYSE:AMPS) from Buy to Neutral and maintained the price target of $5. Altus Power shares closed at $4.87 on Friday. See how other analysts view this stock.
• Susquehanna analyst Mehdi Hosseini downgraded NetApp, Inc. (NASDAQ:NTAP) from Positive to Neutral and lowered the price target from $155 to $130. NetApp shares closed at $122.91 on Friday. See how other analysts view this stock.

Considering buying ILMN stock? Here’s what analysts think:

Read This Next:

• Wall Street’s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields